<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">179</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2018-17-2-84-91</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Subsequent gliomas in survivors of paediatric neoplasms</article-title><trans-title-group xml:lang="ru"><trans-title>Злокачественные глиомы, последовавшие за лечением новообразований у детей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shats</surname><given-names>L. I.</given-names></name><name xml:lang="ru"><surname>Шац</surname><given-names>Л.И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>paediatric oncologist Division of Oncology, Paediatric Oncology and Radiotherapy, Division of Oncology</p><p>Russia 194353, St. Petersburg, Litovskaya str., 2Tel.: +7 (921) 751-3882</p></bio><email>mila.shats@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belogurova</surname><given-names>M. B.</given-names></name><name xml:lang="ru"><surname>Белогурова</surname><given-names>М.Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ozerov</surname><given-names>S. S.</given-names></name><name xml:lang="ru"><surname>Озеров</surname><given-names>С.С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ektova</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Эктова</surname><given-names>А.П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nechesnuk</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Нечеснюк</surname><given-names>А.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rizhova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Рыжова</surname><given-names>М.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vizhlukova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Вужлукова</surname><given-names>О.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Doronina</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Доронина</surname><given-names>И.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsirenova</surname><given-names>H. V.</given-names></name><name xml:lang="ru"><surname>Цыренова</surname><given-names>Х.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Grishina</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Гришина</surname><given-names>Е.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zheludkova</surname><given-names>O. G.</given-names></name><name xml:lang="ru"><surname>Желудкова</surname><given-names>О.Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rudneva</surname><given-names>A. E.</given-names></name><name xml:lang="ru"><surname>Руднева</surname><given-names>А.Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pshonkin</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Пшонкин</surname><given-names>А.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff8"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Erega</surname><given-names>E. P.</given-names></name><name xml:lang="ru"><surname>Ерега</surname><given-names>Е.П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff9"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kumirova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Кумирова</surname><given-names>Э.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff10"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Division of Oncology, Saint-Petersburg State Paediatric Medical University&#13;
St. Petersburg Clinical Research and Practical Center of Specialized Types of Medical Care (Oncologic)</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России, ГБУЗ «Санкт-Петербургский клинический научно-практический центр специализированных видов медицинской помощи (онкологический)»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology,&#13;
Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">N.N. Burdenko Neurosurgical Institute, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ФГАУ «Национальный медицинский исследовательский центр нейрохирургии имени академика Н.Н. Бурденко» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Paediatric Hospital of Murmansk</institution></aff><aff><institution xml:lang="ru">ГОБУЗ «Мурманская детская клиническая больница»</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Buryatia Republican Oncology and Haematology Center, Ulan-Ude</institution></aff><aff><institution xml:lang="ru">Республиканский гематоонкологический центр Республики Бурятия»</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Children's Republican Clinical Hospital, Kazan</institution></aff><aff><institution xml:lang="ru">ГАУЗ «Детская республиканская клиническая больница» Минздрава Республики Татарстан</institution></aff></aff-alternatives><aff-alternatives id="aff7"><aff><institution xml:lang="en">Russian Scientific Center of Roentgenoradiology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский научный центр рентгенорадиологии» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff8"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff9"><aff><institution xml:lang="en">Children's Regional Hospital, Khabarovsk</institution></aff><aff><institution xml:lang="ru">КГБУЗ «Детская краевая клиническая больница»</institution></aff></aff-alternatives><aff-alternatives id="aff10"><aff><institution xml:lang="en">Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-09-20" publication-format="electronic"><day>20</day><month>09</month><year>2018</year></pub-date><volume>17</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>84</fpage><lpage>91</lpage><history><date date-type="received" iso-8601-date="2018-09-20"><day>20</day><month>09</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/179">https://hemoncim.com/jour/article/view/179</self-uri><abstract xml:lang="en"><p>Multimodal therapy has improved survival for most childhood tumours. The development of neoplasms subsequent to therapeutic cranial irradiation is a rare but serious and potentially fatal complication. The analysis included 16 patients (pts.) with subsequent glioblastoma (SG) from several institutions in Russia who underwent cranial or neck irradiation (1 case) to treat their primary disease (acute lymphoblastic leukaemia – 12 pts., medulloblastoma – 2 pts., choroid plexus papilloma – 1 pts., lymphoma – 1 pts.). All gliomas arose within the previous radiation fields and satisfied the widely used criteria for the definition of radiation induced neoplasms. The median RT dose administered was 18 Gy with the dosage ranges being 12–55 Gy. TBI was used in one patient with Ph-positive ALL during bone marrow transplantation. Median latency period was 6 years until diagnosis of SG. The majority of SG (14 of 16) occurred during the initial 9 years of follow-up. Patients underwent surgery resection followed by standard fractionated local radiation and chemotherapy. A Kaplan–Meier analysis was used to illustrate the overall survival (OS) curves. OS rate was 34.4 ± 12.3% and 13,6 ± 9.0% at 1 and 2 years respectively with median 11 months. In case that paediatric neoplasms are treated by standard fractionated radiation or TBI is used, radiation-induced gliomas should be considered as possible long-term side effect. And the patients should be followed for a long term, even long after the period of risk for relapse of the primary cancer has passed.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>paediatric glioma</kwd><kwd>glioblastoma</kwd><kwd>subsequent glioma</kwd><kwd>CNS tumour</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>глиома у детей</kwd><kwd>глиобластома</kwd><kwd>вторая опухоль</kwd><kwd>опухоль ЦНС</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ron E., Modan B., Boice J., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319 (16): 1033-9.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Yeh H.-C., Matanoski G.M., Wang N.,et al. Cancer Incidence after Childhood Nasopharyngeal Radium Irradiation: A Follow-up Study in Washington County, Maryland. Am J Epidemiol 2001; 153 (8): 749-56.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Cahan W.G., Woodard H.Q., Higinbotham N.L., et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1948; 1 (1): 3-29.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Schrantz J.L., Araoz C.A. Radiation induced meningeal fibrosarcoma. Arch Pathol 1972; 93 (1): 26-8.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>National Cancer Institute. NCI Dictionary of Cancer Terms. Retrieved October, 31, 2017 from https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46658.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Pearce M.S., Salotti J.A., Little M.P., et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380 (9840): 499-505.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Banerjee J., Pääkkö E., Harila M., et al. Radiation-induced meningiomas: A shadow in the success story of childhood leukemia. Neuro Oncol 2009; 11 (5): 543-9.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Neglia J., Robison L., Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report From the Childhood Cancer Survivor Study. J Nat Cancer Inst 2006; 98: 1528-37.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bhatia S., Sather H.N., Pabustan O.B.,et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99: 4257-64.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Little M.P., Vathaire F., Shamsaldin A., et al. Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy. International Journal of Cancer 1998; 78 (3): 269-75.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Taylor A.J., Little M.P., Winter D.L., et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 2010; 28: 5287-93.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Brada M., Ford D., Ashley S., et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J 1992; 304 (6838): 1343-6.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Paulino A.C., Mai W.Y., Chintagumpala M., et al. Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys 2008; 71: 1381-7.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Moller T.R., Garwicz S., Barlow L., et al. Decreasing Late Mortality Among Five-Year Survivors of Cancer in Childhood and Adolescence: A Population-Based Study in the Nordic Countries. J Clin Oncol 2001; 19 (13): 3173-81.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Tukenova M., Diallo I., Hawkins M., et al. Long-term Mortality from Second Malignant Neoplasms in 5-Year Survivors of Solid Childhood Tumors: Temporal Pattern of Risk according to Type of Treatment. Cancer Epidemiology Biomarkers &amp; Prevention 2010; 19 (3): 707-15.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Taylor A.J., Frobisher C., Ellison D.W., et al. Survival After Second Primary Neoplasms of the Brain or Spinal Cord in Survivors of Childhood Cancer: Results From the British Childhood Cancer Survivor Study. J Clin Oncol 2009; 27 (34): 5781-7.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Morris E.B., Gajjar A., Okuma J.O., et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 2007; 25: 1532-8.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Musa B.S., Pople I.K., Cummins B.H. Intracranial meningiomas following irradiation--a growing problem? Br J Neurosurg 1995; 9 (5): 629-37.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pettorini B.L., Park Y.S., Caldarelli M., et al. Radiation- induced brain tumours after central nervous system irradiation in childhood: a review. Childs Nerv Syst 2008; 24: 793-805.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Neglia J.P., Inskip P. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 2002; 38: 229-39.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Hancock M.L., Pui C.H., Hudson M.M., et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children’s Research Hospital. J Clin Oncol 1998; 16: 3761-7.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bhatia S., Sather H.N., Pabustan O.B., et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99: 4257-64.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Baker K.S., Defor T.E., Burns L.J., et al. New Malignancies After Blood or Marrow Stem-Cell Transplantation in Children and Adults: Incidence and Risk Factors. J Clin Oncol 2003; 21 (7): 1352-8.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Rosso P., Terracini B., Fears T.R., et al. Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in Italy. International Journal of Cancer 1994; 59 (4): 451-6.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Löning L., Zimmermann M., Reiter A., et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 2000; 95 (9): 2770-5.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Jenkinson H., Hawkins M. Secondary brain tumors in children with ALL. Lancet 1999; 354: 1126.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Hijiya N., Hudson M.M., Lensing S., et al. Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia. JAMA: The Journal of the American Medical Association 2007; 297 (11): 1207-15.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Maule M., Scélo G., Pastore G., et al. Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study. J Nat Cancer Inst 2007; 99 (10): 790-800.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Vinchon M., Leblond P., Caron S., et al. Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Child’s Nervous System 2011; 27 (3): 445-53.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Neglia J.P., Robison L., Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report From the Childhood Cancer Survivor Study. J Nat Cancer Inst 2006; 98: 1528-37.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Carret A.-S., Tabori U., Crooks B., et al. Outcome of secondary high-grade glioma in children previously treated for a malignant condition: A study of the Canadian Pediatric Brain Tumour Consortium. Radiotherapy and Oncology 2006; 81: 33-8.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Walter A., Hancock M., Pui C., et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children’s Research Hospital. J Clin Oncol 1998; 16 (12): 3761-7.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Armstrong G.T., Liu Q., Yasui Y., et al. Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study. J Nat Cancer Inst 2009; 101 (13): 946-58.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Relling M.V., Rubnitz J.E., Rivera G.K., et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34-9.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Чупова Н.В., Самочатова Е.В., Руднева А.Е. и др. Генетический полиморфизм тиопурин-S-метилтрансферазы в лечении детей с острым лимфобластным лейкозом. Гематология и трансфузиология 2005; 50 (6): 3-9.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>SharifS., FernerR., BirchJ.M., etal. Second Primary Tumors in Neurofibromatosis 1 Patients Treated for Optic Glioma: Substantial Risks After Radiotherapy. J Clin Oncol 2006; 24 (16): 2570-5.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Stokkevåg C.H., Engeseth G.M., Ytre-Hauge K.H., et al. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncologica 2014; 53: 8, 1048-105.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Makidono A., Kobayashi N., Manabe A.S.Y., et.al. Metachronous gliomas following cranial irradiation for mixed germ cell tumors. Childs Nerv Syst 2009; 25: 713-8.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Hope A.J., Mansur D.B., Tu P.H., et al. Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma. Childs Nerv Syst 2006; 22: 1201-39.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Sasayama T., Nishihara M., Tanaka K.,et al. Two metachronous tumorsinduced by radiation therapy: case report and review of the literature. J Neurooncol 2008; 88: 315-20.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Kamide T., Nakada M., Hayashi Y., et al Radiation-induced cerebellar high-grade glioma accompanied by meningioma and cavernoma 29 years after the treatment of medulloblastoma: a case report. J Neurooncol 2010; 100: 299-301.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Hah J.O. Anaplastic oligodendroglioma after childhood acute lymphoblastic leukemia: chemotherapy and autologous peripheral blood stem cell transplantation. Pediatr Hematol Oncol 2008; 30 (10): 764-7.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Ahn S.J., Kim I.O. Spinal cord glioblastoma induced by radiation therapy of nasopharyngeal rhabdomyosarcoma with MRI findings: case report. Korean J Radiol 2012; 13 (5): 652-7.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Romeike B.F.M., Kim Y.J., Graf N., et al. Diffuse high-grade gliomas as second malignant neoplasms after radio-chemotherapy for pediatric malignancies. Childs Nerv Syst 2007; 23: 185-193.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Shats L.I., Belogurova M.B., Zheludko-va O.G. Glioblastoma multiforme as a second malignant neoplasm after radio-chemotherapy for pediatric malignancies European Journal of Cancer 2011 Se, Suppl 3: S288.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Wen P.Y., Kesari S. Malignant Gliomas in Adults. New England Journal of Medicine 2008; 359(5): 492-507.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Reardon D.A., Rich J.N., Friedman H.S., et al. Recent Advances in the Treatment of Malignant Astrocytoma. J Clin Oncol 2006; 24 (8): 1253-65.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Banerjee J., Pääkkö E., Harila M., et al. Radiation-induced meningiomas: A shadow in the success story of childhood leukemia. Neuro Oncol 2009; 11 (5): 543-9.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Goshen Y., Stark B., Kornreich L., et al. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatric Blood &amp; Cancer 2007; 49 (3): 294-7.</mixed-citation></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Pääkkö E., Talvensaari K., Pyhtinen J., et al. Late cranial MRI after cranial irradiation in survivors of childhood cancer. Neuroradiology 1994; 36 (8): 652-5.</mixed-citation><mixed-citation xml:lang="ru">Pääkkö E., Talvensaari K., Pyhtinen J., et al. Late cranial MRI after cranial irradiation in survivors of childhood cancer. Neuroradiology 1994; 36 (8): 652-5.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
